Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- For Rutgers Health’s First Chancellor, Mentoring Was the Mission.
- Inspired by a Family’s Struggle, a Scientist Helps Uncover Defense Against Alzheimer’s Disease.
- Researchers Track How Housing Hardships During Childhood Influences Housing Insecurity in Young Adults.
- Parental Monitoring Is Linked to Fewer Teen Conduct Problems Despite Genetic Risk.
- Medicaid Expansion Increases Access to HIV Prevention Medication for High-Risk Populations.
Categories
- Community (2,416)
- Covid (994)
- CTO Events (6)
- News (3,058)
- Pilots (21)